本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Acrivon Therapeutics, Inc.

1.70
-0.1300-7.10%
盤後1.720.0200+1.18%19:59 EDT
成交量:76.50萬
成交額:133.19萬
市值:7,276.24萬
市盈率:-0.90
高:1.90
開:1.85
低:1.70
收:1.83
52周最高:3.56
52周最低:1.27
股本:4,280.14萬
流通股本:2,568.99萬
量比:2.49
換手率:2.98%
股息:- -
股息率:- -
每股收益(TTM):-1.8800
每股收益(LYR):-2.0151
淨資產收益率:-64.63%
總資產收益率:-38.02%
市淨率:0.84
市盈率(LYR):-0.84

資料載入中...

2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

SEC問詢函

Form CORRESP - Correspondence
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/13

SEC問詢函

Form CORRESP - Correspondence
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]